Inflammatory processes are increasingly recognized in the pathogenesis of the vascular remodeling that characterizes pulmonary arterial hypertension (PAH). Chronic inflammation may contribute to disease progression or serve as a biomarker of PAH severity. Furthermore, inflammatory pathways may represent possible therapeutic targets for novel PAH-specific drugs beyond the currently approved therapies targeting the endothelin, nitric oxide/cyclic GMP, and prostacyclin biological pathways. The main focus of this article is to provide recent advances in the understanding of the role of inflammatory pathways in the pathogenesis of PAH from preclinical studies and current clinical data supporting chronic inflammation in PAH patients and to discuss emerging therapeutic implications. © 2021 American Physiological Society. Compr Physiol 11:1805-1829, 2021.

Inflammatory Mechanisms in the Pathogenesis of Pulmonary Arterial Hypertension: Recent Advances / Mercurio, V.; Cuomo, A.; Naranjo, M.; Hassoun, P. M.. - In: COMPREHENSIVE PHYSIOLOGY. - ISSN 2040-4603. - 11:2(2021), pp. 1805-1829. [10.1002/cphy.c200025]

Inflammatory Mechanisms in the Pathogenesis of Pulmonary Arterial Hypertension: Recent Advances

Mercurio V.;Cuomo A.;
2021

Abstract

Inflammatory processes are increasingly recognized in the pathogenesis of the vascular remodeling that characterizes pulmonary arterial hypertension (PAH). Chronic inflammation may contribute to disease progression or serve as a biomarker of PAH severity. Furthermore, inflammatory pathways may represent possible therapeutic targets for novel PAH-specific drugs beyond the currently approved therapies targeting the endothelin, nitric oxide/cyclic GMP, and prostacyclin biological pathways. The main focus of this article is to provide recent advances in the understanding of the role of inflammatory pathways in the pathogenesis of PAH from preclinical studies and current clinical data supporting chronic inflammation in PAH patients and to discuss emerging therapeutic implications. © 2021 American Physiological Society. Compr Physiol 11:1805-1829, 2021.
2021
Inflammatory Mechanisms in the Pathogenesis of Pulmonary Arterial Hypertension: Recent Advances / Mercurio, V.; Cuomo, A.; Naranjo, M.; Hassoun, P. M.. - In: COMPREHENSIVE PHYSIOLOGY. - ISSN 2040-4603. - 11:2(2021), pp. 1805-1829. [10.1002/cphy.c200025]
File in questo prodotto:
File Dimensione Formato  
mercurio cuomo compr physiol 2021.pdf

solo utenti autorizzati

Licenza: Accesso privato/ristretto
Dimensione 399.57 kB
Formato Adobe PDF
399.57 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11588/868945
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 6
  • ???jsp.display-item.citation.isi??? 6
social impact